1
|
Lauria PSS, Gomes JDM, Abreu LS, Santana RC, Nunes VLC, Couto RD, Colavolpe PO, Silva MSD, Soares MBP, Villarreal CF. Ayahuasca and its major component harmine promote antinociceptive effects in mouse models of acute and chronic pain. J Ethnopharmacol 2024; 323:117710. [PMID: 38184028 DOI: 10.1016/j.jep.2024.117710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Revised: 12/20/2023] [Accepted: 01/02/2024] [Indexed: 01/08/2024]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Ayahuasca (AYA) is a psychedelic brew used in religious ceremonies. It is broadly used as a sacred medicine for treating several ailments, including pain of various origins. AIM OF THE STUDY To investigate the antinociceptive effects of AYA and its mechanisms in preclinical models of acute and chronic pain in mice, in particular during experimental neuropathy. MATERIALS AND METHODS The antinociceptive effects of AYA administered orally were assessed in the following models of pain: formalin test, Complete Freund's Adjuvant (CFA)-induced inflammation, tail flick test, and partial sciatic nerve ligation model of neuropathic pain. Antagonism assays and Fos immunohistochemistry in the brain were performed. AYA-induced toxicity was investigated. AYA was chemically characterized. The antinociceptive effect of harmine, the major component present in AYA, was investigated. RESULTS AYA (24-3000 μL/kg) dose-dependently reduced formalin-induced pain-like behaviors and CFA-induced mechanical allodynia but did not affect CFA-induced paw edema or tail flick latency. During experimental neuropathy, single treatments with AYA (24-3000 μL/kg) reduced mechanical allodynia; daily treatments once or twice a day for 14 days promoted consistent and sustained antinociception. The antinociceptive effect of AYA (600 μL/kg) was reverted by bicuculline (1 mg/kg) and methysergide (5 mg/kg), but not by naloxone (5 mg/kg), phaclofen (2 mg/kg), and rimonabant (10 mg/kg), suggesting the roles of GABAA and serotonergic receptors. AYA increased Fos expression in the ventrolateral periaqueductal gray and nucleus raphe magnus after 1 h, but not after 6 h or 14 days of daily treatments. AYA (600 μL/kg) twice a day for 14 days did not alter mice's motor function, spontaneous locomotion, body weight, food and water intake, hematological, biochemical, and histopathological parameters. Harmine (3.5 mg/kg) promoted consistent antinociception during experimental neuropathy. CONCLUSIONS AYA promotes consistent antinociceptive effects in different mouse models of pain without inducing detectable toxic effects. Harmine is at least partially accountable for the antinociceptive properties of AYA.
Collapse
Affiliation(s)
| | - Juliana de Medeiros Gomes
- Department of Pharmaceutical Sciences, Federal University of Paraíba, 58.050-585, João Pessoa, PB, Brazil.
| | - Lucas Silva Abreu
- Chemistry Institute, Fluminense Federal University, 24.020-150, Niterói, RJ, Brazil.
| | | | | | - Ricardo David Couto
- School of Pharmacy, Federal University of Bahia, 40.170-115, Salvador, BA, Brazil; School of Medicine, University Center of Technology and Science, 41.800-700, Salvador, BA, Brazil.
| | | | - Marcelo Sobral da Silva
- Department of Pharmaceutical Sciences, Federal University of Paraíba, 58.050-585, João Pessoa, PB, Brazil.
| | - Milena Botelho Pereira Soares
- Gonçalo Moniz Institute, FIOCRUZ, 40.296-710, Salvador, BA, Brazil; Institute of Advanced Systems in Health, SENAI CIMATEC, 41.650-010, Salvador, BA, Brazil.
| | - Cristiane Flora Villarreal
- School of Pharmacy, Federal University of Bahia, 40.170-115, Salvador, BA, Brazil; Gonçalo Moniz Institute, FIOCRUZ, 40.296-710, Salvador, BA, Brazil.
| |
Collapse
|
2
|
Paolla Raimundo E Silva J, Raimundo E Silva JP, Silva Vasconcelos PG, Targino Campos L, de Medeiros Gomes J, Tolentino Leite Filho M, Menezes RPBD, Scotti MT, Tavares JF, Cristina Barbosa Silva A, Costa EMMDB. The potential of Acmella oleracea as a nutraceutical source for the symptomatic treatment of Burning Mouth Syndrome. Nat Prod Res 2023:1-7. [PMID: 37671677 DOI: 10.1080/14786419.2023.2253974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/07/2023]
Abstract
This study analysed the phytochemical profile of Acmella oleracea extract and the molecular interactions of its main compounds with TRPV1 and CB2, target receptors in the Burning Mouth Syndrome (BMS) pathogenesis. The phytochemical profile of A. oleracea's floral buds extract treated with activated charcoal (TCEE) was analysed by High-Performance Liquid Chromatography (HPLC) coupled to Mass Spectrometry (LC-MS). The quantification of spilanthol was analysed by HPLC coupled to a Diode-Array Detector (HPLC-DAD). The phytochemical analysis revealed the presence of nine alkylamides and phenolic compounds. The TCEE showed a significant increase in spilanthol content compared to the crude extract (CEE), going from 28.33 mg/g to 117.96 mg/g. The molecular docking indicated a behaviour of the alkylamides as partial TRPV1 agonists and CB2 agonists and, for the first time, indicates the action of these compounds in the symptomatic management of BMS.
Collapse
Affiliation(s)
| | | | | | - Letícia Targino Campos
- Postgraduate Programme in Dentistry, State University of Paraiba, Campina Grande, Brazil
| | - Juliana de Medeiros Gomes
- Postgraduate Programme in Natural and Synthetic Bioactive Products, Federal University of Paraiba, João Pessoa, Brazil
| | | | | | - Marcus Tullius Scotti
- Postgraduate Programme in Natural and Synthetic Bioactive Products, Federal University of Paraiba, João Pessoa, Brazil
| | - Josean Fechine Tavares
- Postgraduate Programme in Natural and Synthetic Bioactive Products, Federal University of Paraiba, João Pessoa, Brazil
| | | | | |
Collapse
|
3
|
de Medeiros Gomes J, Cahino Terto MV, Golzio do Santos S, Sobral da Silva M, Fechine Tavares J. Seasonal Variations of Polyphenols Content, Sun Protection Factor and Antioxidant Activity of Two Lamiaceae Species. Pharmaceutics 2021; 13:pharmaceutics13010110. [PMID: 33467160 PMCID: PMC7829895 DOI: 10.3390/pharmaceutics13010110] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2020] [Revised: 01/06/2021] [Accepted: 01/13/2021] [Indexed: 12/20/2022] Open
Abstract
Secondary metabolite production by plants is influenced by external environmental factors that can change depending on the seasons, which makes it important to know how the plant, through its metabolism, is able to adapt to these variations. Mentha x villosa and Plectranthus amboinicus present in their chemical composition polyphenols, and through previous studies, it has been seen that these two species present promising in vitro photoprotective activity. The aim of this study was to evaluate seasonal alterations in photoprotective and antioxidant activities and the influence of factors such as precipitation levels and sun radiation incidence. Thus, polyphenol quantification, cromatographics (HPLC-DAD) and multivariate (PCA) analyses of extracts of the two species through twelve months were done. It was observed that the best months for photoprotective and antioxidant activities were September for M. villosa and July for P. amboinicus (SPF = 14.79). It was possible to conclude that solar radiation more clearly influences the production of phenolics and the increase of SPF in M. villosa, in addition to favoring the antioxidant activity of the two species, while precipitation seems to have no influence.
Collapse
|